Atrial fibrillation

Japan Society for the Promotion of ScienceJP¥87.1mNational Institute for Health and Care Research£10.8mAmerican Heart AssociationUS$4.2m

• Effect of GLP-1 Medications on Atrial Fibrillation Burden and Progression

  American Heart AssociationRegent UniversityUS$300k2026–2028

• Biomarker research on atrial fibrillation treatment strategies for preventing complications

  Japan Society for the Promotion of ScienceInstitute of Science TokyoJP¥4.6m2026–2029

• The role of DNA methylation alterations in the increased risk of heart failure and atrial fibrillation during aging

  Fonds Wetenschappelijk OnderzoekResearch Foundation Flanders2026–2029

• Centre of Research Excellence for Atrial Fibrillation (AF-CARE) to Reduce Burden of Disease

  National Health and Medical Research CouncilUniversity of AdelaideA$3m2025–2030

• Cardiovascular Health, Physical Activity, and Outcomes in Women with Atrial Fibrillation

  American Heart Association2025–2027

• Future Innovations in Novel Detection of Atrial Fibrillation after Stroke: Regulatory approvals and API integration to enable use in the NHS

  National Institute for Health and Care ResearchUniversity of Leeds£88.3k2025–2026

• Research for risk factors and sex differences of atrial fibrillation onset using genetic methods.

  Japan Society for the Promotion of ScienceInstitute of Science TokyoJP¥4.6m2024–2027

• Cardiovascular Risk reduction in Atrial Fibrillation Trial (CRAFT)

  Japan Society for the Promotion of ScienceFukuoka UniversityJP¥17.2m2024–2027

• Cost-effectiveness analysis of systematic screening for atrial fibrillation

  Japan Society for the Promotion of ScienceKyoto Prefectural University of MedicineJP¥650k2023–2025

• Towards phenotype-specific diagnostic and treatment strategies in atrial fibrillation and heart failure with preserved ejection fraction

  National Institute for Health and Care ResearchKing's College London£1.2m2023–2028